News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
10985
Sources here
16
Companies here
35
Search results Stored financial headlines

Active search

10985 matching headlines

Ticker or company: RMMain company stories
Clear

Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M

* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Traws Pharma GAAP EPS of -$0.16 beats by $0.06

* Traws Pharma press release [https://seekingalpha.com/pr/20620150-traws-pharma-reports-q2-2026-financial-results-and-provides-business-highlights] (TRAW [https://seekingalpha.com/symbol/TRAW]): Q2 GAAP EPS of -$0.16 beats by $0.06. * Cash and cash equivalents: As of June 30, 2026, the Company had cash and cash equivalents of $5.0 million, compared to $3.8 million as of December 31, …

TRAW main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% · Next-week setup negative 40.7% TRAW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Permian Basin Royalty Trust (NYSE:PBT): Why Is Energy Income in Focus Today?

Permian Basin Royalty Trust (NYSE:PBT) is under scrutiny as an energy income vehicle, with its latest update prompting an examination of how well its energy income is supported by operational execution rather than general market sentiment. The article emphasizes that for royalty trusts, cash …

PBT main company
Sharemaestro market context Trend signal active 52 weeks +102.2% · Next-week setup positive 65.5% PBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale

Thermo Fisher Scientific (TMO) stock has gained 20.7% over the last year and appears modestly undervalued by about 7.6% according to a Discounted Cash Flow (DCF) model, suggesting it's close to its intrinsic value. While a recent sale of its microbiology business and focus …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Short Interest in Direxion Daily META Bull 2X Shares (NASDAQ:METU) Rises By 84.0%

Short interest in Direxion Daily META Bull 2X Shares (NASDAQ:METU) increased by 84.0% in July, reaching 7.90 million shares, which represents 45.4% of shares outstanding. The leveraged ETF, which provides twice the daily exposure to Meta Platforms' stock, trades below its 52-week high and …

META main company
Sharemaestro market context Price below Trend Line 52 weeks -21.6% META stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Securities Fraud Investigation Into Armstrong World Industries, Inc. (AWI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP has launched a securities fraud investigation into Armstrong World Industries, Inc. (AWI) following a significant drop in its stock price. The investigation stems from the company's Q4 and full-year 2025 financial results, which missed consensus estimates and revealed …

AWI main company
Sharemaestro market context Price above Trend Line 52 weeks -7.1% · Next-week setup positive 56.5% AWI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044

Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …

VNDA main company
Sharemaestro market context Price below Trend Line 52 weeks +9.9% VNDA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Under Armour’s Turnaround Hits a Wall as North America Demand Craters

Under Armour, Inc. (NYSE:UAA)'s long-running turnaround just got tougher. On August 7, the athletic clothing manufacturer forecasted a sharper annual revenue decline, and investors responded by sending shares down as much as 9% in early trade, showing the market's lack of patience for a …

UAA main company U1AI34 main company UAA main company UAA main company UAC main company
Sharemaestro market context Price below Trend Line 52 weeks -2.1% UAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next

Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …

TARS main company
Sharemaestro market context Price above Trend Line 52 weeks +20.9% · Next-week setup positive 62.0% TARS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Meta to face massive social media addiction trial Tuesday

Meta (META) will face off against attorneys general from several states in an Oakland, Calif., courtroom Tuesday as part of a major lawsuit alleging that the company violated child safety and consumer protection laws and harmed children's mental health. The trial, which begins on …

META80 main company META main company M1TA34 main company META main company META main company META main company +2 more
Sharemaestro market context Price below Trend Line 52 weeks -17.8% META80 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next

Ascendis Pharma A/S reported strong Q2 results, with revenues beating expectations by 2.8% and statutory profit exceeding forecasts by 104%. Analysts have subsequently upgraded their EPS estimates for 2026, though the consensus price target remains unchanged at US$310. The company is expected to continue …

ASND main company
Sharemaestro market context Trend signal active 52 weeks +27.9% ASND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Russian Attacks Destroy ArcelorMittal in Kryvyi Rih and Kyiv Book Market

Russian forces conducted missile and drone strikes on August 16, targeting civilian and industrial infrastructure in Ukraine. In Kryvyi Rih, an attack on the ArcelorMittal plant killed two workers, injured 13, and partially halted production. Simultaneously, a large-scale fire destroyed sections of Kyiv's historic …

MT main company
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup positive 58.0% MT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management Makes New $19.78 Million Investment in Ormat Technologies, Inc. $ORA

Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management has made a new $19.78 million investment in Ormat Technologies, Inc. (NYSE:ORA), acquiring 181,665 shares. This makes Ormat its 11th-largest holding, representing 2.6% of its portfolio. The investment comes as Ormat Technologies reported strong …

ORA main company
Sharemaestro market context Price below Trend Line 52 weeks +21.4% ORA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

612,850 Shares in Agios Pharmaceuticals, Inc. $AGIO Acquired by SCS Capital Management LLC

SCS Capital Management LLC acquired 612,850 shares of Agios Pharmaceuticals (NASDAQ:AGIO) during the second quarter, valued at approximately $22.7 million. The biopharmaceutical company reported a quarterly loss per share of $1.69, missing estimates, but exceeded revenue expectations with $44.75 million. Analyst sentiment for AGIO …

AGIO main company
Sharemaestro market context Trend signal active 52 weeks -13.5% AGIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Two killed as Russia targets Kryvyi Rih with missiles and drones

A Russian missile and drone attack on Kryvyi Rih overnight on August 15-16 killed two people and injured 13, damaging two industrial facilities, including the ArcelorMittal steel plant. The attack forced a partial halt to production at the steel plant, which sustained damage to …

MT main company
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup positive 58.0% MT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

State of Wyoming Buys New Position in Performance Food Group Company $PFGC

The State of Wyoming has acquired a new position in Performance Food Group Company (NYSE:PFGC), purchasing 12,407 shares valued at approximately $1.39 million in the second quarter. This move is part of broader institutional investment, with such entities owning 96.87% of the company. Despite …

PFGC main company
Sharemaestro market context Trend signal active 52 weeks +5.2% PFGC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioMarin Pharmaceutical (BMRN) Updates Guidance And Files Shelf Registration, Is It Still Below Fair Value?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has just given investors a packed update, including second quarter 2026 results, fresh earnings guidance for the rest of the …

BMRN main company B1MR34 main company BMRN main company BMRN main company
Sharemaestro market context New activity signal 52 weeks +11.9% · Next-week setup negative 4.6% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bitcoin Miner Riot Platforms Just Signed a $9 Billion Compute Deal With Anthropic. Why AI Is Now the Key to Valuing Bitcoin Mining Stocks.

Bitcoin mining company Riot Platforms recently secured a significant $9 billion, 20-year agreement to provide AI compute services to Anthropic, with potential for an additional $7 billion from extensions. This deal highlights a growing trend among Bitcoin miners to pivot their data center infrastructure …

RIOT main company
Sharemaestro market context Trend signal active 52 weeks +43.8% RIOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Riot Platforms signs $9B AI compute deal with Anthropic, shifts from Bitcoin mining

Riot Platforms has signed a significant $9 billion compute agreement with AI company Anthropic, involving 191 megawatts of capacity from Riot's Rockdale, Texas facility over 20 years. This deal marks a strategic pivot for Riot away from Bitcoin mining and towards AI data-center infrastructure, …

RIOT main company
Sharemaestro market context Trend signal active 52 weeks +43.8% RIOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kinsale Capital Group Inc. Has $9.24 Million Stake in CarMax, Inc. $KMX

Kinsale Capital Group Inc. significantly increased its stake in CarMax, Inc. by 18.8% in Q2 2026, bringing its total holdings to 174,637 shares valued at $9.24 million. Despite recent insider purchases and a "Strong Buy" upgrade from Zacks, CarMax carries an average "Hold" rating …

KMX main company
Sharemaestro market context Trend signal active 52 weeks -0.2% KMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oppenheimer Asset Management Inc. Takes $5.01 Million Position in FormFactor, Inc. $FORM

Oppenheimer Asset Management Inc. has acquired a new position in FormFactor, Inc. (NASDAQ:FORM) during the second quarter, purchasing 31,330 shares valued at approximately $5.01 million. This comes as FormFactor reported stronger-than-expected quarterly results with earnings of $0.82 per share and revenue of $258.24 million, …

FORM main company
Sharemaestro market context Trend signal started 52 weeks +351.3% · Next-week setup positive 55.0% FORM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO

Simplify Asset Management Inc. increased its stake in Thermo Fisher Scientific Inc. (TMO) by 32.6% in the second quarter, purchasing 5,670 additional shares. This brings their total holding to 23,079 shares, valued at approximately $11.6 million. Institutional investors collectively own 89.23% of TMO, with …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HM Payson & Co. Sells 20,885 Shares of Thermo Fisher Scientific Inc. $TMO

HM Payson & Co. reduced its stake in Thermo Fisher Scientific Inc. by 11.3%, selling 20,885 shares but still holding 163,790 shares valued at $82.1 million. Despite insider selling of over $30.6 million in the last 90 days, Thermo Fisher reported strong quarterly results …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context